Generics

A Look at the Year in Generics

September 09, 2020

The generic pipeline continues to provide significant value to payers and patients as key products in top therapeutic classes lose patent protection.

Generic Drug Shortage Solutions on the Horizon

September 04, 2020

Pharmacy organizations stress that government initiatives must include an overall plan for drug pricing, payment model, and supply chain transparency.

To “Buy American” Generic Drugs, Pharmacists Must Be Adequately Reimbursed

August 20, 2020

Why do we pharmacists buy generics from foreign manufacturers? The answer is pure and simple: the cost.

Mylan Launches Generic Version of Multiple Sclerosis Treatment

August 20, 2020

Mylan has launched the first FDA-approved generic version of Biogen’s dimethyl fumarate (Tecfidera) for relapsing forms of multiple sclerosis.

The Pharmacist’s Role in Generic Substitution

August 10, 2020

Pharmacists are in a unique position to recommend cost-saving generics and counsel patients on generic substitution.

Study Compares Cost, Accessibility of Novel Cancer Drugs in US and India

August 07, 2020

The advent of generic and biosimilar medicines for novel treatments has helped bridge the gap in the delivery of cancer care between the United States and India, according to the study.

Sandoz to Supply Critical Injectable Generic Medications to Hospitals

July 14, 2020

Sandoz is collaborating with Civica Rx to provide critical injectable generic medicines to hospitals to help reduce supply shortages.

Out-of-Pocket Costs Declined for Generic Drugs Available Through Discount Programs

July 13, 2020

Medicare beneficiary out-of-pocket costs for generic drugs used to treat chronic conditions declined from 2009 to 2017.

Coronavirus News Roundup: Vaccine Trials Gaining Momentum, Pharmacists Fight Racism Amid COVID-19

June 26, 2020

Check out this week's most important coronavirus-related news.

Demand for Generic Steroid Spikes After Preliminary COVID-19 Results

June 25, 2020

Demand for an affordable generic steroid soared after preliminary findings from a study showed it may be effective in reducing deaths from the coronavirus disease 2019 (COVID-19).